Chinook Therapeutics, Inc. (formerly Aduro)
2 clinical trials · Sponsor
◉ Watch Chinook Therapeutics, Inc. (formerly Aduro)
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer (NCT03937141) | Chinook Therapeutics, Inc. (formerly Aduro) | 2019-08-26 |
| Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or Lymphomas (NCT02675439) | Chinook Therapeutics, Inc. (formerly Aduro) | 2016-04-28 |
Track Chinook Therapeutics, Inc. (formerly Aduro) automatically
Every clearance here is in the API, with alerts when new ones post.